key: cord-1033656-rz3e1bpp
authors: Norman, Francesca F; Chamorro, Sandra; Braojos, Francisco; López-Miranda, Elena; Chamorro, Jesús; González, Irene; Martín, Oihane; Pérez-Molina, José-Antonio
title: Strongyloides in bronchoalveolar lavage fluid: Practical implications in the COVID-19 era
date: 2021-07-22
journal: J Travel Med
DOI: 10.1093/jtm/taab114
sha: 5ee26d6a9c5002ee23048a0db2e463119b82c990
doc_id: 1033656
cord_uid: rz3e1bpp

Latent infections caused by Strongyloides sp. may become symptomatic years after initial exposure in endemic areas especially in specific contexts such as following administration of corticosteroids (for COVID-19 or other diseases). Heightened awareness of these reactivations and timely diagnosis may be critical to prevent complications and improve outcome.

Certain helminth infections such as strongyloidiasis may be underdiagnosed in nonendemic areas due to the presence of asymptomatic individuals, the lack of awareness of the disease and the poor sensitivity of diagnostic methods. Life-threatening complications of these infections may occur especially in patients with altered immune responses. 1

A 69 year-old Colombian male presented with abdominal pain and vomiting. He had been living in Spain for 20 years and had last traveled to his country 6 years previously.

The patient was receiving treatment with prednisone 5mg daily and docetaxel, atezolizumab and ipatasertib as part of a clinical trial for stage IV prostate cancer with bone metastases.

On examination he was afebrile, basal oxygen saturation 96%, with normal renal/hepatic function, mild neutrophilia (12900 neutrophils/uL) and no eosinophilia.

Nasopharyngeal PCR for SARS-CoV-2 was negative; pneumococcal antigen in urine was positive. Chest X-ray showed interstitial diffuse bilateral infiltrates.

In the following hours he developed progressive shortness of breath (oxygen saturation 80%). An urgent CT pulmonary angiogram confirmed bilateral pulmonary infiltrates and ruled out pulmonary emboli (see figure) .

He was admitted on antibiotic treatment with levofloxacin and piperacillin-tazobactam and iv methylprednisolone (drug-induced pulmonary toxicity could not be excluded).

Due to lack of improvement iv gancyclovir was initiated (CMV viremia was positive in blood, 2200 IU/mL). Strongyloides infection, especially in the current pandemic era, is thus warranted.

All authors contributed to the clinical management of the patient and interpretation of the data. FFN wrote the paper, the co-authors reviewed the final draft.

Support was provided by the Instituto de Salud Carlos III project "RD16/0027/0020" Red de Enfermedades Tropicales, Subprograma RETICS del Plan Estatal de I +D+I

There are no conflicts of interest to declare 

COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection

Strongyloides stercoralis hyperinfection syndrome: a case series and a review of the literature

Dexamethasone in Hospitalized Patients with Covid-19 -Preliminary Report

Report: Disseminated Strongyloidiasis in a Patient with COVID-19

Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia

Reactivation of Strongyloides stercoralis in patients with SARS-CoV-2 pneumonia receiving dexamethasone

Epub ahead of print

World Health Organization